Cardiovascular Disease

Blacks With Diabetes and CKD Have Higher CVD Risk

Blacks With Diabetes and CKD Have Higher CVD Risk

Odds of cardiovascular mortality 14.8% higher in black Americans with both conditions.

Safety Profile Varies for Add-On Second-Line Diabetes Drugs

Safety Profile Varies for Add-On Second-Line Diabetes Drugs

For patients taking metformin, TZD and DPP-4i linked to lower mortality, cardiovascular risks.

Liraglutide Cuts CV Events in High-Risk Type 2 Diabetes Patients

Liraglutide Cuts CV Events in High-Risk Type 2 Diabetes Patients

There was also a 22% reduction in the development of renal outcomes with liraglutide compared to placebo.

FDA Warns of OTC Diarrhea Drug Abuse

FDA Warns of OTC Diarrhea Drug Abuse

When taken in higher-than-recommended amounts, loperamide can cause cardiovascular conditions.

Post-Kidney Transplant Mortality Linked to Pre-Existing Heart Disease

Post-Kidney Transplant Mortality Linked to Pre-Existing Heart Disease

By

Coronary artery disease before transplantation increases death risk by 77%, study finds.

Air Pollution Linked With Higher CVD Risk in Diabetes Patients

Air Pollution Linked With Higher CVD Risk in Diabetes Patients

Patients exposed to high levels of air pollution have an elevated risk of cardiovascular disease.

Low HRQoL May Increase CV Event Risk in CKD Patients

Low HRQoL May Increase CV Event Risk in CKD Patients

By

The researchers found no relationship between poor quality of life and CKD progression.

Food Industry Needs to Reduce Sodium, FDA Says

Food Industry Needs to Reduce Sodium, FDA Says

The FDA has developed 2- and 10-year goals to reduce sodium content in both processed and prepared foods.

Higher HDL-C Linked to Cardiac Risk in Diabetics With Low LDL-C

Higher HDL-C Linked to Cardiac Risk in Diabetics With Low LDL-C

Increased risk for cardiovascular events and all-cause mortality for patients with type 2 diabetes.

Kidney Function Decline Tied to CV Events in Diabetics

Kidney Function Decline Tied to CV Events in Diabetics

Renal function decline is independent factor for cardiovascular risk in patients with type 2 diabetes.

Heart Failure Risk Increases With First Heart Attack

Heart Failure Risk Increases With First Heart Attack

One in 4 MI survivors develop heart failure within 4 years.

HDL-C Prediction of CVD Is Affected by TG, LDL-C

HDL-C Prediction of CVD Is Affected by TG, LDL-C

Cardiovascular disease risk is elevated when low HDL-C was accompanied by LDL-C and triglycerides.

High Sodium Intake May Up CVD Risk in CKD Patients

High Sodium Intake May Up CVD Risk in CKD Patients

By

CKD patients with daily sodium above 4,548 mg may help protect their cardiovascular health by reducing sodium in their diets, researchers suggested.

High Uric Acid Increases Risk of Non-Fatal Stroke in CKD Patients

High Uric Acid Increases Risk of Non-Fatal Stroke in CKD Patients

By

Odds of non-fatal stroke are 49% higher in patients in the fourth quartile of uric acid level versus those in the second quartile.

Lower SBP Target Reduces CVD Events, Mortality in Elderly

Lower SBP Target Reduces CVD Events, Mortality in Elderly

By

The findings warrant reconsideration of blood pressure targets for many patients older than 75, according to an editorial.

Half of Myocardial Infarctions Are Silent

Half of Myocardial Infarctions Are Silent

45% of all myocardial infarctions studied were silent MIs.

Low Salt Intake May Harm Cardiovascular Health, Study Says

Low Salt Intake May Harm Cardiovascular Health, Study Says

Researchers say restricting sodium might backfire, but heart experts are critical of the finding.

Taking Aspirin After TIA Prevents Stroke, Study Confirms

Taking Aspirin After TIA Prevents Stroke, Study Confirms

Researchers find risk is reduced by as much as 80%.

Blood Pressure Trends Help Predict Stroke

Blood Pressure Trends Help Predict Stroke

Odds increase with rapid rise in middle age.

Blood Pressure Control Beneficial for Seniors, SPRINT Shows

Blood Pressure Control Beneficial for Seniors, SPRINT Shows

Latest findings from national trial show it lowers chances of heart failure, even in older adults.

CABG Better Than PCI in End-Stage Renal Disease

CABG Better Than PCI in End-Stage Renal Disease

Updated review and meta-analysis show beneficial effect for CABG for long-term mortality.

Number of Calcified Arteries Helps Predict CVD Events

Number of Calcified Arteries Helps Predict CVD Events

The number of CAC vessels allowed researchers to correctly estimate the likelihood of both coronary heart disease and cardiovascular disease.

Aspirin Safe for Partial Nephrectomy Patients

Aspirin Safe for Partial Nephrectomy Patients

Findings among patients on chronic antiplatelet therapy for cardioprotection.

LDL Improvement in Hypertriglyceridemia Depends on Statin

LDL Improvement in Hypertriglyceridemia Depends on Statin

LDL-C and triglyceride reductions depend on choice and dose of statin prescribed.

Life's Simple 7 Can Prevent Chronic Kidney Disease

Life's Simple 7 Can Prevent Chronic Kidney Disease

Preventing cardiovascular disease through adherence to Life's Simple 7 can also prevent the development of CKD.

Hyperkalemia After AMI Frequent, Potentially Dangerous

Hyperkalemia After AMI Frequent, Potentially Dangerous

By

In-hospital mortality risk was more than double among patients whose hyperkalemia persisted than those whose potassium levels normalized.

Hyperkalemia Common in Clinical Practice

Hyperkalemia Common in Clinical Practice

By

Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia.

Cardiovascular Risk Does Not Differ for GLP-1 Receptor Agonists

Cardiovascular Risk Does Not Differ for GLP-1 Receptor Agonists

Researchers found no significant differences in instances of CVD in patients treated with GLP-1RA compared to DPP-4i in combination with metformin.

Depressed Coronary Artery Disease Patients Have Higher Risks

Depressed Coronary Artery Disease Patients Have Higher Risks

Female gender and more severe angina based on Canadian Cardiovascular Society class were considered predictors of depression.

Evacetrapib Does Not Reduce CV Events in Diabetes Patients With CHD

Evacetrapib Does Not Reduce CV Events in Diabetes Patients With CHD

Evacetrapib did lower low-density lipoprotein cholesterol in high vascular risk patients, but did not reduce major cardiovascular events.

Sign Up for Free e-newsletters